histamine has been researched along with Colitis, Mucous in 21 studies
Excerpt | Relevance | Reference |
---|---|---|
"We previously showed that mucosal biopsy supernatants from irritable bowel syndrome patients activated neurons despite low concentrations of tryptase, histamine, and serotonin which individually would not cause spike discharge." | 7.85 | Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients. ( Annahazi, A; Ceyhan, GO; Demir, IE; Krueger, D; Michel, K; Ostertag, D; Schemann, M; Zeller, F, 2017) |
" We showed that decreasing intake of fermentable carbohydrates improved abdominal pain in patients with IBS, and this was accompanied by changes in the gut microbiota and decreased urinary histamine concentrations." | 4.12 | Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. ( Baerg, L; Bai, X; Bercik, P; Beyak, M; Caminero, A; Collins, SM; De Palma, G; Jaramillo-Polanco, J; Jimenez-Vargas, N; Lomax, AE; Lopez-Lopez, C; Lu, J; Madsen, K; Manzar, A; Pigrau, M; Pinto-Sanchez, MI; Pujo, J; Rabbia, V; Reed, DE; Sessenwein, J; Shimbori, C; Surette, MG; Vanner, SJ; Verdu, EF; Yu, Y; Zhang, Y, 2022) |
"The article presents an analysis of the literature on food intolerance (FS) associated with the presence in the diet of fermentable oligodimosaccharides and polyols FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols), histamine and food additives." | 4.12 | [Food intolerances and the small intestine]. ( Parfenov, AI, 2022) |
"The aim of this study was to investigate the efficacy and safety of the novel complex drug, consisting of released-active form of antibodies to S-100 protein, tumor necrosis factor-α and histamine, (Kolofort) under outpatient conditions in patients with functional dyspepsia (FD), irritable bowel syndrome (IBS), and FD-IBS overlap." | 3.91 | Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT. ( Epstein, OI; Glazunov, AB; Ivashkin, VT; Poluektova, EA; Putilovskiy, MA, 2019) |
"We previously showed that mucosal biopsy supernatants from irritable bowel syndrome patients activated neurons despite low concentrations of tryptase, histamine, and serotonin which individually would not cause spike discharge." | 3.85 | Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients. ( Annahazi, A; Ceyhan, GO; Demir, IE; Krueger, D; Michel, K; Ostertag, D; Schemann, M; Zeller, F, 2017) |
" The dose-response curves show an analytical range between 5 and 200 nM of histamine, corresponding to physiologically normal conditions while higher concentrations correlate with disease." | 1.56 | Towards a catheter-based impedimetric sensor for the assessment of intestinal histamine levels in IBS patients. ( Cornelis, P; Doll, T; Peeters, M; Putzeys, T; Tack, J; Troost, F; Van de Cauter, L; Verhaert, N; Wackers, G; Wagner, P; Wübbenhorst, M, 2020) |
"The term "food allergy" is widely misused for all sorts of symptoms and diseases caused by food." | 1.35 | [Food allergy, food intolerance or functional disorder?]. ( Wüthrich, B, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (19.05) | 29.6817 |
2010's | 6 (28.57) | 24.3611 |
2020's | 11 (52.38) | 2.80 |
Authors | Studies |
---|---|
Fukudo, S | 1 |
Kano, M | 1 |
Sato, Y | 1 |
Muratsubaki, T | 1 |
Kanazawa, M | 1 |
Tashiro, M | 1 |
Yanai, K | 1 |
Hasler, WL | 1 |
Grabauskas, G | 1 |
Singh, P | 1 |
Owyang, C | 1 |
De Palma, G | 2 |
Shimbori, C | 1 |
Reed, DE | 2 |
Yu, Y | 1 |
Rabbia, V | 1 |
Lu, J | 1 |
Jimenez-Vargas, N | 1 |
Sessenwein, J | 1 |
Lopez-Lopez, C | 1 |
Pigrau, M | 1 |
Jaramillo-Polanco, J | 1 |
Zhang, Y | 1 |
Baerg, L | 1 |
Manzar, A | 1 |
Pujo, J | 1 |
Bai, X | 1 |
Pinto-Sanchez, MI | 1 |
Caminero, A | 1 |
Madsen, K | 2 |
Surette, MG | 1 |
Beyak, M | 1 |
Lomax, AE | 1 |
Verdu, EF | 1 |
Collins, SM | 1 |
Vanner, SJ | 1 |
Bercik, P | 2 |
Ray, K | 1 |
Keszthelyi, D | 1 |
Parfenov, AI | 1 |
Ivashkin, VT | 1 |
Poluektova, EA | 1 |
Glazunov, AB | 1 |
Putilovskiy, MA | 1 |
Epstein, OI | 1 |
Wackers, G | 1 |
Putzeys, T | 1 |
Peeters, M | 1 |
Van de Cauter, L | 1 |
Cornelis, P | 1 |
Wübbenhorst, M | 1 |
Tack, J | 1 |
Troost, F | 1 |
Verhaert, N | 1 |
Doll, T | 1 |
Wagner, P | 1 |
Uranga, JA | 1 |
Martínez, V | 1 |
Abalo, R | 1 |
Perna, E | 1 |
Aguilera-Lizarraga, J | 1 |
Florens, MV | 1 |
Jain, P | 1 |
Theofanous, SA | 1 |
Hanning, N | 1 |
De Man, JG | 1 |
Berg, M | 1 |
De Winter, B | 1 |
Alpizar, YA | 1 |
Talavera, K | 1 |
Vanden Berghe, P | 1 |
Wouters, M | 1 |
Boeckxstaens, G | 1 |
Brizuela, M | 1 |
Castro, J | 1 |
Harrington, AM | 1 |
Brierley, SM | 1 |
Ostertag, D | 1 |
Annahazi, A | 1 |
Krueger, D | 1 |
Michel, K | 2 |
Demir, IE | 1 |
Ceyhan, GO | 1 |
Zeller, F | 2 |
Schemann, M | 2 |
Potter, MDE | 1 |
Goodsall, TM | 1 |
Walker, MM | 1 |
Talley, NJ | 1 |
Böhn, L | 1 |
Störsrud, S | 1 |
Törnblom, H | 1 |
Bengtsson, U | 1 |
Simrén, M | 1 |
Mearin, F | 1 |
Rey, E | 1 |
Balboa, A | 1 |
McIntosh, K | 1 |
Schneider, T | 1 |
Dang, F | 1 |
Keshteli, AH | 1 |
Vanner, S | 1 |
Stoianov, SG | 1 |
Penchev, PI | 1 |
Gerova, VA | 1 |
Tsenova, VG | 1 |
Wüthrich, B | 1 |
Buhner, S | 1 |
Li, Q | 1 |
Vignali, S | 1 |
Barbara, G | 2 |
De Giorgio, R | 2 |
Stanghellini, V | 2 |
Cremon, C | 2 |
Langer, R | 1 |
Daniel, H | 1 |
Carini, G | 1 |
Wang, B | 1 |
Vasina, V | 1 |
Cogliandro, RF | 1 |
Grundy, D | 1 |
Tonini, M | 1 |
De Ponti, F | 1 |
Corinaldesi, R | 1 |
Wood, JD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Microbiota and Quality of Life for a Low FODMAPs Versus Standard Dietary Advice in Patients With Irritable Bowel Syndrome[NCT02902926] | 120 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | |||
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study[NCT01829932] | 30 participants (Actual) | Interventional | 2013-04-30 | Completed | |||
Molecular Phenotyping of IBS Subtypes[NCT03653689] | 110 participants (Actual) | Interventional | 2018-09-10 | Completed | |||
A Study Evaluating the Effects of Low and High FODMAP Diets on Mucosal Protease Nerve Interactions in IBS Patients[NCT03221790] | 20 participants (Anticipated) | Interventional | 2017-11-01 | Not yet recruiting | |||
Investigating Serotonin Signalling in IBD Patients[NCT01650311] | 60 participants (Anticipated) | Observational | 2012-07-31 | Recruiting | |||
A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome[NCT00583128] | Phase 2 | 117 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for histamine and Colitis, Mucous
Article | Year |
---|---|
Histamine Neuroimaging in Stress-Related Disorders.
Topics: Animals; Brain; Depressive Disorder, Major; Doxepin; Female; Histamine; Humans; Hypnotics and Sedati | 2022 |
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
Topics: Diarrhea; Histamine; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Mast Cells; Peptide Hydrol | 2022 |
Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.
Topics: Abdominal Pain; Amino Acids; Animals; Cannabidiol; Constipation; Diarrhea; Dietary Supplements; Eati | 2020 |
Pruritogenic mechanisms and gut sensation: putting the "irritant" into irritable bowel syndrome.
Topics: Colon; Histamine; Humans; Hyperalgesia; Irritable Bowel Syndrome; Mast Cells; Visceral Pain | 2021 |
[Functional and motor gastrointestinal disorders].
Topics: Antidepressive Agents; Biomarkers; Constipation; Diarrhea; Dietary Carbohydrates; Dietary Fiber; Div | 2015 |
1 trial available for histamine and Colitis, Mucous
Article | Year |
---|---|
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Dicarboxylic Acids; Diet; Feces; Female; Gastrointesti | 2017 |
15 other studies available for histamine and Colitis, Mucous
Article | Year |
---|---|
Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice.
Topics: Abdominal Pain; Animals; Carbohydrates; Gastrointestinal Microbiome; Histamine; Hyperalgesia; Irrita | 2022 |
Bacterial histamine and abdominal pain in IBS.
Topics: Abdominal Pain; Histamine; Humans; Irritable Bowel Syndrome | 2022 |
Histamine-Producing Bacteria: The Missing Link in Irritable Bowel Syndrome?
Topics: Bacteria; Histamine; Humans; Irritable Bowel Syndrome | 2023 |
[Food intolerances and the small intestine].
Topics: Disaccharides; Duodenum; Fermentation; Food Additives; Food Intolerance; Histamine; Humans; Irritabl | 2022 |
Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
Topics: Adult; Ambulatory Care; Antibodies; Drug Combinations; Dyspepsia; Female; Health Surveys; Histamine; | 2019 |
Towards a catheter-based impedimetric sensor for the assessment of intestinal histamine levels in IBS patients.
Topics: Biomimetics; Biosensing Techniques; Catheters; Dielectric Spectroscopy; Electric Impedance; Electrod | 2020 |
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS.
Topics: Adult; Animals; Capsaicin; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Ent | 2021 |
Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients.
Topics: Adult; Aged; Biopsy; Enteric Nervous System; Female; Histamine; Humans; Intestinal Mucosa; Irritable | 2017 |
Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience.
Topics: Abdominal Pain; Adult; Dyspepsia; Gastritis; Histamine; Humans; Irritable Bowel Syndrome | 2020 |
Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
Topics: Adult; Aged; Anxiety; Biogenic Amines; Depression; Diet; Dietary Carbohydrates; Dietary Fats; Eating | 2013 |
Histamine, 5-hydroxytriptamine, collagen, mast cells and Ig-secreting cells in the small bowel disorders with diarrhea.
Topics: Adult; Antibody-Producing Cells; Celiac Disease; Chronic Disease; Diarrhea; Enteritis; Female; Hista | 2008 |
[Food allergy, food intolerance or functional disorder?].
Topics: Adult; Child; Child, Preschool; Cross Reactions; Diagnosis, Differential; Food Hypersensitivity; Gas | 2009 |
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Topics: Action Potentials; Adult; Aged; Biopsy; Case-Control Studies; Cell Extracts; Colon; Constipation; Di | 2009 |
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Topics: Abdominal Pain; Adult; Animals; Cell Count; Enterochromaffin Cells; Female; Histamine; Humans; Intes | 2011 |
Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies.
Topics: Enteritis; Food Hypersensitivity; Histamine; Humans; Ileum; Intestinal Mucosa; Intestine, Large; Int | 2006 |